Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

MS&AD Ventures participated in a $4.75m round for anti-phishing software startup Clearedin, which plans to invest the cash in recruitment.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.

The Alphabet-backed space launch services provider has raised cash from Ontario Teachers’ Pension Plan as it targets $314m at a likely $33.3bn pre-money valuation.

Morphic began trading on the Nasdaq Global Market yesterday after issuing 6 million shares priced at $15 each, providing exits to AbbVie, GSK, Novo, Pfizer, Schrödinger and ShangPharma.

Shares in Adaptive Biotechnologies, backed by Microsoft, Celgene, Illumina, LabCorp and BD Biosciences, soared more than 100% on its first day of trading.

Novel Group-backed luxury goods marketplace The RealReal will raise $300m in an initial public offering in which it will float above its range.

Ladi Greenstreet has left his US-based head of healthcare position at Accenture Ventures to become the unit's head of UK and Ireland.

Just over a year after securing an initial $50m, fusion energy technology developer Commonwealth Fusion Systems has closed its Eni-backed series A round with $115m in capital.